Süleyman Akarsu
Research Subjects
Research Interests
Süleyman Akarsu has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Murat Erdem
Gulhane Military Medical Faculty, Department of Psychiatry, Ankara-Turkey
4 shared publications - Deniz Torun
Department of Medical Genetics, Gülhane Faculty of Medicine University of Health Sciences Ankara Turkey
2 shared publications - Özcan Uzun
Saglik Bilimleri Universitesi
2 shared publications - Abdullah Bolu
Department of Psychiatry, Eskişehir Military Hospital, Eskişehir, Turkey
1 shared publication Adem Balıkcı
1 shared publicationAli Doruk
Department of Psychiatry, Gulhane Military Medical Academy, Ankara, Turkey
1 shared publication
Latest Publications
- 1 September 2015
- Published by Elsevier in Journal of Affective Disorders
- Vol. 184, 160-163
Mitochondrial complex I and III mRNA levels in bipolar disorder
- 1 September 2015
- Published by Elsevier in Journal of Affective Disorders
- Vol. 184, 160-163
Mitochondrial complex I and III mRNA levels in bipolar disorder
- 1 January 2015
- Vol. 52 (3) , 60-4
Psychiatric Symptoms and Quality of Life in Military Personnel Deployed Abroad.
Military personnel deployed abroad could be exposed to more risk factors that adversely affect quality of life. In this study, we examined psychiatric symptoms and quality of life in Turkish Armed Forces deployed to Afghanistan. A total of 289 Turkish military personnel working in Afghanistan enrolled in this study. They completed two surveys containing questions about socio-demographic characteristics. Data were collected and analyzed from 258 of the participants. The general symptom scores (GSI) were above 1 in 20.8 Percent (n=54) of the participants. The lowest SF-36 scores by the sub-groups were mental health (59.14 ± 18.56) and vitality (59.25 ± 21.17). The highest score was in the physical function subscale (84.42 ± 19.53). All Quality of Life Questionnaire Short Form (SF-36)subscale scores were lower in the GSI above 1 group than the GSI below 1 group. In the GSI above 1 group: education level and depression affected SF-36 physical functioning; paranoid ideation and somatization affected SF-36 role limitations due to physical health; age and somatization affected SF-36 pain; age affected SF-36 general health; phobic anxiety affected SF-36 vitality; age, tenure of occupation, tenure abroad; and phobic anxiety affected SF-36 mental health. The negative effects of psychiatric symptoms on the quality of life were similar to those in the general population and in specific disease groups. These results should be considered when evaluating the mental health of military personnel deployed abroad.
- 1 January 2015
- Vol. 52 (3) , 60-4
Psychiatric Symptoms and Quality of Life in Military Personnel Deployed Abroad.
Military personnel deployed abroad could be exposed to more risk factors that adversely affect quality of life. In this study, we examined psychiatric symptoms and quality of life in Turkish Armed Forces deployed to Afghanistan. A total of 289 Turkish military personnel working in Afghanistan enrolled in this study. They completed two surveys containing questions about socio-demographic characteristics. Data were collected and analyzed from 258 of the participants. The general symptom scores (GSI) were above 1 in 20.8 Percent (n=54) of the participants. The lowest SF-36 scores by the sub-groups were mental health (59.14 ± 18.56) and vitality (59.25 ± 21.17). The highest score was in the physical function subscale (84.42 ± 19.53). All Quality of Life Questionnaire Short Form (SF-36)subscale scores were lower in the GSI above 1 group than the GSI below 1 group. In the GSI above 1 group: education level and depression affected SF-36 physical functioning; paranoid ideation and somatization affected SF-36 role limitations due to physical health; age and somatization affected SF-36 pain; age affected SF-36 general health; phobic anxiety affected SF-36 vitality; age, tenure of occupation, tenure abroad; and phobic anxiety affected SF-36 mental health. The negative effects of psychiatric symptoms on the quality of life were similar to those in the general population and in specific disease groups. These results should be considered when evaluating the mental health of military personnel deployed abroad.
- Open Access
- 10 December 2014
- Published by Springer Nature in Journal of Molecular Psychiatry
- Vol. 2 (1) , 6
Mitochondrial complex I and III gene mRNA levels in schizophrenia, and their relationship with clinical features
Journal of Molecular Psychiatry is closed and is no longer accepting submissions. You may wish to submit to another BioMed Central journal. Please visit the BioMed Central website for a complete list of our journals. BioMed Central will continue to host an archive of all articles previously published in the journal, and all articles published in Journal of Molecular Psychiatry will remain fully searchable via the BioMed Central website.
- 10 December 2014
- Published by Springer Nature in Journal of Molecular Psychiatry
- Vol. 2 (1) , 6
Open AccessMitochondrial complex I and III gene mRNA levels in schizophrenia, and their relationship with clinical features
Journal of Molecular Psychiatry is closed and is no longer accepting submissions. You may wish to submit to another BioMed Central journal. Please visit the BioMed Central website for a complete list of our journals. BioMed Central will continue to host an archive of all articles previously published in the journal, and all articles published in Journal of Molecular Psychiatry will remain fully searchable via the BioMed Central website.
- Open Access
- 1 January 2014
- Published by International Scientific Information, Inc. in American Journal of Case Reports
- Vol. 15, 69-73
A rare symptom in posttraumatic stress disorder: Spontaneous ejaculation
Background: Sexual dysfunction is reported to occur more frequently in posttraumatic stress disorder (PTSD) patients than in the general population. Herein, we present the case of a patient with spontaneous ejaculation that developed when severity ...
- 1 January 2014
- Published by International Scientific Information, Inc. in American Journal of Case Reports
- Vol. 15, 69-73
Open AccessA rare symptom in posttraumatic stress disorder: Spontaneous ejaculation
Background: Sexual dysfunction is reported to occur more frequently in posttraumatic stress disorder (PTSD) patients than in the general population. Herein, we present the case of a patient with spontaneous ejaculation that developed when severity ...
- Open Access
- 1 January 2014
- Published by Turk Noropsikiyatri Dernegi in Archives of Neuropsychiatry
Polikistik over sendromu olan hastalarda depresyon, anksiyete ve öfke
- 1 January 2014
- Published by Turk Noropsikiyatri Dernegi in Archives of Neuropsychiatry
Open AccessPolikistik over sendromu olan hastalarda depresyon, anksiyete ve öfke
- Open Access
- 1 January 2013
- Published by ScopeMed in Psikiyatride Güncel Yaklaşımlar
- Vol. 5 (3) , 299-312
Neurobiology of Placebo Effect
Placebo is defined as a substance or method that has no specific effect on the condition being treated. Placebo leads to the state of contentment and shows its effects just like a drug by the pathways in the body. Various changes formed by plasebo on the brain activation, neurotransmitters and hormones have been observed with the development of neuroimaging methods. The effects of dopamine, serotonin, and opioid systems in the formation of the placebo response; the relationship between placebo effect, reward cycle and expectation process and the role of the some specific regions in the brain where pharmacological agents acting on during the placebo response have been shown in several studies. There are similarities between hypnosis and the placebo effects and expectation of improvement is closely related to the suggesting phenomenon in the hypnosis as well as placebo responses. The formation of similar changes in the brain after administration of placebo and hypnosis associated with the expectation models and suggestions attracts attention. Neurochemical pathways in the brain constitute functional impact with many of the common mechanisms. Therefore, all of these mechanisms in the placebo response can take part in relation to each other. Although it is known that many factors may influence, understanding of the effects of placebo and viewing the changes in the brain formed by placebo have an important place for enlightening roles of psychological factors in the onset of diseases and treatment
- 1 January 2013
- Published by ScopeMed in Psikiyatride Güncel Yaklaşımlar
- Vol. 5 (3) , 299-312
Open AccessNeurobiology of Placebo Effect
Placebo is defined as a substance or method that has no specific effect on the condition being treated. Placebo leads to the state of contentment and shows its effects just like a drug by the pathways in the body. Various changes formed by plasebo on the brain activation, neurotransmitters and hormones have been observed with the development of neuroimaging methods. The effects of dopamine, serotonin, and opioid systems in the formation of the placebo response; the relationship between placebo effect, reward cycle and expectation process and the role of the some specific regions in the brain where pharmacological agents acting on during the placebo response have been shown in several studies. There are similarities between hypnosis and the placebo effects and expectation of improvement is closely related to the suggesting phenomenon in the hypnosis as well as placebo responses. The formation of similar changes in the brain after administration of placebo and hypnosis associated with the expectation models and suggestions attracts attention. Neurochemical pathways in the brain constitute functional impact with many of the common mechanisms. Therefore, all of these mechanisms in the placebo response can take part in relation to each other. Although it is known that many factors may influence, understanding of the effects of placebo and viewing the changes in the brain formed by placebo have an important place for enlightening roles of psychological factors in the onset of diseases and treatment